Matches in Wikidata for { <http://www.wikidata.org/entity/Q97596526> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q97596526 description "article scientifique publié en 2020" @default.
- Q97596526 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97596526 description "scientific article published on 20 July 2020" @default.
- Q97596526 description "wetenschappelijk artikel" @default.
- Q97596526 description "наукова стаття, опублікована 20 липня 2020" @default.
- Q97596526 name "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 name "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 type Item @default.
- Q97596526 label "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 label "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 prefLabel "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 prefLabel "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 P1433 Q97596526-FBB214CC-1B40-4813-B010-C9C5AE7EBB2D @default.
- Q97596526 P1476 Q97596526-EC36AED0-3F91-41D6-86B6-2DA7541E9497 @default.
- Q97596526 P2093 Q97596526-3E17B889-DDF0-4F9C-B8A2-0CFF855808F9 @default.
- Q97596526 P2093 Q97596526-58E15CC5-3602-4E36-8CC5-C52AE7A8C71A @default.
- Q97596526 P2093 Q97596526-69CF5678-4149-4A26-8825-50886E176E87 @default.
- Q97596526 P2093 Q97596526-8CA1DD3B-50AA-4CCC-8932-AC1D192C0C32 @default.
- Q97596526 P2093 Q97596526-CB40C2DD-BE21-4F3C-B90F-E454BAF5502A @default.
- Q97596526 P2093 Q97596526-EA59EB0C-831A-44AB-9682-132610693291 @default.
- Q97596526 P31 Q97596526-75301054-5E0E-4888-B617-AAE55E6AC3E3 @default.
- Q97596526 P356 Q97596526-23CE81C9-BDFF-44D2-BA00-ED38F0A1FDFC @default.
- Q97596526 P50 Q97596526-157ECBE0-5143-48D3-9405-97DE6899FFD4 @default.
- Q97596526 P50 Q97596526-3F72A6F1-6FC5-4D74-8BF6-0447452C876F @default.
- Q97596526 P577 Q97596526-0C6B13C8-410A-4B55-B3D7-0D105BB2B743 @default.
- Q97596526 P698 Q97596526-9386978B-CBA0-4543-BA3C-D62FEAB44613 @default.
- Q97596526 P921 Q97596526-0D8682C5-F1B3-4193-9AC8-6CA1E561A242 @default.
- Q97596526 P356 CAM4.3227 @default.
- Q97596526 P698 32687266 @default.
- Q97596526 P1433 Q27724564 @default.
- Q97596526 P1476 "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" @default.
- Q97596526 P2093 "Gajanan Bhat" @default.
- Q97596526 P2093 "István Láng" @default.
- Q97596526 P2093 "Klára Mezei" @default.
- Q97596526 P2093 "Patrick Wayne Cobb" @default.
- Q97596526 P2093 "Shanta Chawla" @default.
- Q97596526 P2093 "Yong Wha Moon" @default.
- Q97596526 P31 Q13442814 @default.
- Q97596526 P356 "10.1002/CAM4.3227" @default.
- Q97596526 P50 Q61148553 @default.
- Q97596526 P50 Q96019803 @default.
- Q97596526 P577 "2020-07-20T00:00:00Z" @default.
- Q97596526 P698 "32687266" @default.
- Q97596526 P921 Q30314101 @default.